Canadian application, no grantCanada
Carbinols for the treatment of neuropathic dysfunction
CA 2463518 A1 · Owner: Endo Pharmaceuticals Inc. · Inventors: Lee, David A. H.; Carliss, Richard
Overview
Drawings and full text
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Compositions and methods are provided for treating neuropathic pain or neuropathic dysfunction that include the administration of an effective amount of a defined carbinol or a pharmaceutically acceptable salt or prodrug thereof.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 16, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended October 16, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 16, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledOctober 16, 2002
GrantedNo grant recorded
Term endedOctober 16, 2022
Patent numberCA 2463518 A1
Classification (IPC)A61K31/40 +2 more
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.